Advertisement

Topics

ImmunoGen, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 05012018] Prices from USD $175

23:56 EST 2 Mar 2018 | BioPortfolio Reports

ImmunoGen, Inc. Strategy, SWOT and Corporate Finance Report


Summary


ImmunoGen, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


ImmunoGen, Inc. ImmunoGen or the company' is a developer of targeted anticancer therapeutics using its antibodydrug conjugate ADC technology. The ADC technology is comprised of the company's portfolio of cancercell killing agents that can be attached to antibodies for targeted delivery to cancer cells. ImmunoGen is headquartered in Waltham, Massachusetts, and employed 317 people as of June 30, 2015.


Scope


Detailed information on ImmunoGen, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting ImmunoGen, Inc. in the form of a SWOT analysis

An indepth view of the business model of ImmunoGen, Inc. including a breakdown and examination of key business segments

Intelligence on ImmunoGen, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about ImmunoGen, Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of ImmunoGen, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess ImmunoGen, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on ImmunoGen, Inc.'s business structure, strategy and prospects.

Original Article: ImmunoGen, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 05012018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "ImmunoGen, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 05012018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...